My Moves Matter

Keeping up with NDRC alum My Moves Matter led by founder Richelle Flanagan ✅ Pilot study launched with University College Cork, with a second study to launch in H2 this year with Prof Elena Moro, president-elect of the European Academy of Neurology in France. This is a world-first in tracking neurological symptoms across hormonal stages in Parkinson's. ✅ 1000 app users on the My Moves Matter platform, which empowers people with Parkinson’s Disease to live their best lives. ✅ Winner of Local Enterprise Week Technological University Dublin Pitch Perfect Final last month. Read more about the startup that completed both the NDRC #FounderWeekend and #PreAccelerator with RDI Hub: https://lnkd.in/e4-pFDpe

Neurosexism: could this app bridge the gender gap in Parkinson’s disease? https://lnkd.in/e2-QJKgQ My Moves Matter Richelle Flanagan University College Cork #womenshealth #health #parkinsons #parkinsonsdisease #neurology #gendergap #womenintech #womeninbusiness #womenentrepreneurs #womenfounders #femalefounders #femaleentrepreneurs #tech #healthtech #femtech #innovation #future #research #ireland

At PharmStars we so enjoy celebrating 🎉 good news updates 👏 from our fantastic #PharmStarsAlumni 🚀 . As a #DigitalHealth #Accelerator, nothing pleases us more than, well, acceleration 💫 ! Here is the latest and greatest from our graduates:   ✴ Deliberate AI announced their first AI-COA™ model, for Depression and Anxiety measurement and has been accepted into the FDA’s Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program. ✴ Head Diagnostics received coverage in the Business Post and was awarded “Best Application of AI in Healthcare” at The AI Awards https://lnkd.in/eEv4H44M ✴ Lana Feng, Ph.D. Feng, CEO of Huma.AI, published an article in Forbes about GenAI in healthcare and life sciences. ✴ Michael Cloutier joined KEEP Health’s advisory board to support their mission to change the way people store, manage, and monitor medication at home. ✴ My Moves Matter announced a pilot study "Tracking Parkinson’s Disease (PD) symptoms, medications, and menstruation,” the first study in the world to track how hormonal changes in women with Parkinson’s impacts symptoms. ✴  Prism.bio closed a major expansion of a contract with a top three pharma client and received investments of $150K from Merck, Northpond Ventures, and McKesson Ventures. ✴ viO HealthTech announced a collaboration to provide patients with greater access to critical health data in managing their health. ✴  Vistim Labs celebrated the release of their second product (gen2) and embarked on their first Lewy Body Disease study with the University of Miami.   Hoping for good news for your #startup? PharmStars can help! If your startup offers a #digitalhealth #innovation that #pharma can use, consider applying to join one of our cohorts. See our website for more information and to receive updates by mail www.pharmstars.com     

"Tracking Parkinson’s Disease (PD) symptoms, medications, and menstruation" We are delighted to announce our pilot study "Tracking Parkinson’s Disease (PD) symptoms, medications, and menstruation" in collaboration with researchers from the Department of Anatomy and Neuroscience, School of Medicine at the University College Cork, Ireland. The research will be the first in the world to track how #hormonal changes in women with Parkinson’s impacts their symptoms. It is hoped that their findings will aid patient-specific treatment and management of hashtag #Parkinson’s disease. The study with UCC is so important for hashtag #womenwithParkinson’s as it will be the first prospective study of its kind to track the impact of the #menstrualcycle on #Parkinson’s symptoms. There are no clinical guidelines for the management of symptoms worsening in relation to hormonal changes in women. Professor Aideen Sullivan, Head of Department of Anatomy and Neuroscience and lead researcher on the study said: “There is increasing global awareness of the unmet need for patient-specific treatment and management of Parkinson’s disease. This is particularly important for women with Parkinson’s, who have unique needs. Women may experience Parkinson’s symptoms differently at distinct stages of their monthly menstrual cycle, and of their reproductive lifecycle. " Co-lead on the study, Dr Lucy Collins Stack, said: “The knowledge gained from this study will further the advancement of gender specific treatment for women during the peri-menstrual period.” https://lnkd.in/eCycCdVC